https://www.selleckchem.com/pr....oducts/abraxane-nab-
ase I/IIa study provides safety data for 68Ga-NeoBOMB1, a promising radiopharmaceutical for targeting GRPR-expressing tumors. Safety profiles and pharmacokinetics are suitable for PET imaging and absorbed dose estimates are comparable to other 68Ga-labelled radiopharmaceuticals used in clinical routine. Copyright © 2020 by the Society of Nuclear Medicine and Molecular Imaging, Inc.BACKGROUND Past research in population health trends has shown that injuries form a substantial burden of population health loss. Regular upda
Like
Comment
Share
